143 related articles for article (PubMed ID: 33786269)
1. A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus.
Hu A; Koh B; Teo MR
Diabetol Int; 2021 Apr; 12(2):145-150. PubMed ID: 33786269
[TBL] [Abstract][Full Text] [Related]
2. Application of the Ipswich Touch Test for diabetic peripheral neuropathy screening: a systematic review and meta-analysis.
Zhao N; Xu J; Zhou Q; Li X; Chen J; Zhou J; Zhou F; Liang J
BMJ Open; 2021 Oct; 11(10):e046966. PubMed ID: 34607858
[TBL] [Abstract][Full Text] [Related]
3. The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration.
Sharma S; Kerry C; Atkins H; Rayman G
Diabet Med; 2014 Sep; 31(9):1100-3. PubMed ID: 24673517
[TBL] [Abstract][Full Text] [Related]
4. Interprofessional Validation of the Ipswich Touch Test in Adults With Diabetes: The Canadian Experience.
McLaren AM; Lu SH
Can J Diabetes; 2023 Feb; 47(1):38-42. PubMed ID: 36050256
[TBL] [Abstract][Full Text] [Related]
5. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting.
Bowling FL; Abbott CA; Harris WE; Atanasov S; Malik RA; Boulton AJ
Diabet Med; 2012 Dec; 29(12):1550-2. PubMed ID: 22672290
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study.
Adams OP; Herbert JR; Howitt C; Unwin N
Diabet Med; 2019 Dec; 36(12):1629-1636. PubMed ID: 31094005
[TBL] [Abstract][Full Text] [Related]
7. Screening for the loss of protective sensation in people without a history of diabetic foot ulceration: Validation of two simple tests in India.
Chatzistergos PE; Kumar S; Sumathi CS; Mahadevan S; Vas P; Chockalingam N
Diabetes Res Clin Pract; 2023 Aug; 202():110810. PubMed ID: 37391033
[TBL] [Abstract][Full Text] [Related]
8. Is it possible to substitute the monofilament test for the Ipswich Touch Test in screening for peripheral diabetic neuropathy?
Dutra LMA; Moura MC; do Prado FA; De Oliveira Lima G; Melo MC; Fernandez RNM; Novaes MRCG
Diabetol Metab Syndr; 2020; 12():27. PubMed ID: 32266011
[TBL] [Abstract][Full Text] [Related]
9. Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience.
Madanat A; Sheshah E; Badawy el-B; Abbas A; Al-Bakheet A
Prim Care Diabetes; 2015 Aug; 9(4):304-6. PubMed ID: 25466160
[TBL] [Abstract][Full Text] [Related]
10. The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration.
Rayman G; Vas PR; Baker N; Taylor CG; Gooday C; Alder AI; Donohoe M
Diabetes Care; 2011 Jul; 34(7):1517-8. PubMed ID: 21593300
[TBL] [Abstract][Full Text] [Related]
11. Comparing the Ipswich Touch Test (IpTT) and 10gm-SMWF (10-gm Semmes-Weinstein mono-filament) in Indian population subset with type 2 diabetes mellitus to detect diabetes neuropathy.
Senthilkumar S; Dasarathan R; Pazhani P; Gaur A; Sakthivadivel V
Ir J Med Sci; 2023 Dec; 192(6):2793-2799. PubMed ID: 37140765
[TBL] [Abstract][Full Text] [Related]
12. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
[TBL] [Abstract][Full Text] [Related]
13. Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus.
Pafili K; Trypsianis G; Papazoglou D; Maltezos E; Papanas N
Diabetes Ther; 2020 Apr; 11(4):979-986. PubMed ID: 32172390
[TBL] [Abstract][Full Text] [Related]
14. 4.5-gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients.
Saltzman CL; Rashid R; Hayes A; Fellner C; Fitzpatrick D; Klapach A; Frantz R; Hillis SL
J Bone Joint Surg Am; 2004 Apr; 86(4):717-23. PubMed ID: 15069135
[TBL] [Abstract][Full Text] [Related]
15. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
[TBL] [Abstract][Full Text] [Related]
16. Simple screening tests for peripheral neuropathy in the diabetes clinic.
Perkins BA; Olaleye D; Zinman B; Bril V
Diabetes Care; 2001 Feb; 24(2):250-6. PubMed ID: 11213874
[TBL] [Abstract][Full Text] [Related]
17. ACP Journal Club: the Ipswich Touch Test at home had 78% sensitivity and 94% specificity for detecting loss of foot sensation.
O'Loughlin A; Dinneen SF
Ann Intern Med; 2015 Feb; 162(4):JC10. PubMed ID: 25686185
[No Abstract] [Full Text] [Related]
18. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
[TBL] [Abstract][Full Text] [Related]
19. Validity and Reliability Diabetic Foot Check-up as a Simple Screening Test of Diabetic Foot Ulcers in a Community.
Bubun J; Yusuf S; Syam Y; Hidayat W; Majid S
Int J Low Extrem Wounds; 2023 Jun; ():15347346231178181. PubMed ID: 37287241
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of SET--a new device for the measurement of pain perception in comparison to standard measures of diabetic neuropathy.
Nguyen M; Henniges W; Lobisch M; Reifert S; Larbig M; Pfützner A; Forst T
Diabetes Technol Ther; 2004 Oct; 6(5):601-6. PubMed ID: 15628814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
